• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核性和恶性胸腔积液的鉴别诊断:Th1/Th2 细胞因子谱、肿瘤标志物谱和化学谱的比较。

Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.

机构信息

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

出版信息

Scand J Clin Lab Invest. 2020 Jul;80(4):265-270. doi: 10.1080/00365513.2020.1728784. Epub 2020 Feb 28.

DOI:10.1080/00365513.2020.1728784
PMID:32108543
Abstract

The differentiation between tuberculous plural effusion (TPE) and malignant plural effusion (MPE) remains a major clinical challenge in the diagnosis and management of pleural effusions, especially in developing countries with a high incidence of tuberculosis. We aimed to evaluate the diagnostic value of cytokines, tumor markers and biochemical markers in the differentiation of TPE and MPE. Two hundred and forty-two patients were included, of whom 134 were diagnosed with MPE and 108 were diagnosed with TPE. In total, 12 markers were tested in pleural effusion samples from all subjects: Interleukin-2 (IL-2), Tumor necrosis factor alpha (TNF-α), Interferon (IFN)-γ, interleukins-4, 6, 10 (IL-4,6,10), cytokeratin-19 fragment (CYFRA 21-1), carcinoembryonic antigen (CEA), neuron specific enolase (NSE), adenosine deaminase (ADA), lactate dehydrogenase (LDH) and high sensitivity C- reactive protein (Hs-CRP). The diagnostic value of each marker was evaluated and compared by receiver operating characteristic (ROC) curves. In the 12 markers evaluated, TNF-α, IFN-γ, IL-6, CYFRA 21-1, CEA, ADA and Hs-CRP were significantly different between the TPE and MPE groups, and the areas under the ROC curves were 0.624, 0.942, 0.619, 0.808, 0.903, 0.842 and 0.917, respectively. IFN-γ showed a better diagnostic performance than the other markers. With a cut-off value of >2.45 pg/mL, the sensitivity and specificity of IFN-γ were 91.11 and 91.94%, respectively. TNF-α, IFN-γ, IL-6, CYFRA 21-1, CEA, ADA and Hs-CRP were useful in the differentiation between the TPE and MPE groups. IFN-γ showed a better diagnostic performance than the multitude of other markers evaluated in this study, which is satisfactory for the discrimination of TPE and MPE.

摘要

结核性胸腔积液(TPE)和恶性胸腔积液(MPE)的鉴别诊断仍然是胸腔积液诊断和管理中的主要临床挑战,特别是在结核病发病率较高的发展中国家。我们旨在评估细胞因子、肿瘤标志物和生化标志物在 TPE 和 MPE 鉴别诊断中的价值。共纳入 242 例患者,其中 134 例诊断为 MPE,108 例诊断为 TPE。共检测了所有受试者胸腔积液样本中的 12 种标志物:白细胞介素-2(IL-2)、肿瘤坏死因子-α(TNF-α)、干扰素(IFN)-γ、白细胞介素-4、6、10(IL-4、6、10)、细胞角蛋白 19 片段(CYFRA 21-1)、癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、腺苷脱氨酶(ADA)、乳酸脱氢酶(LDH)和高敏 C 反应蛋白(Hs-CRP)。通过接收者操作特征(ROC)曲线评估和比较每种标志物的诊断价值。在评估的 12 种标志物中,TPE 和 MPE 组之间 TNF-α、IFN-γ、IL-6、CYFRA 21-1、CEA、ADA 和 Hs-CRP 差异有统计学意义,ROC 曲线下面积分别为 0.624、0.942、0.619、0.808、0.903、0.842 和 0.917。IFN-γ 的诊断性能优于其他标志物。当截断值为>2.45pg/ml 时,IFN-γ 的灵敏度和特异性分别为 91.11%和 91.94%。TNF-α、IFN-γ、IL-6、CYFRA 21-1、CEA、ADA 和 Hs-CRP 有助于 TPE 和 MPE 组的鉴别。IFN-γ 的诊断性能优于本研究评估的多种其他标志物,对 TPE 和 MPE 的鉴别是令人满意的。

相似文献

1
Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.结核性和恶性胸腔积液的鉴别诊断:Th1/Th2 细胞因子谱、肿瘤标志物谱和化学谱的比较。
Scand J Clin Lab Invest. 2020 Jul;80(4):265-270. doi: 10.1080/00365513.2020.1728784. Epub 2020 Feb 28.
2
Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interleukin-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.肿瘤坏死因子-α、干扰素-γ、白细胞介素-10及腺苷脱氨酶2在结核性胸腔积液与恶性胸腔积液鉴别诊断中的诊断准确性
J Cardiothorac Surg. 2014 Jul 1;9:118. doi: 10.1186/1749-8090-9-118.
3
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.胸腔干扰素-γ释放试验联合生物标志物可有效鉴别结核性胸腔积液和恶性胸腔积液。
BMC Infect Dis. 2019 Jan 16;19(1):55. doi: 10.1186/s12879-018-3654-z.
4
Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.胸腔积液中白细胞介素 27、干扰素-γ 和腺苷脱氨酶联合检测对结核性胸膜炎的诊断价值。
Chin Med J (Engl). 2013;126(17):3215-21.
5
Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.肿瘤标志物在鉴别肺腺癌相关恶性胸腔积液与结核性胸腔积液中的应用。
Am J Med Sci. 2024 Aug;368(2):136-142. doi: 10.1016/j.amjms.2024.04.001. Epub 2024 Apr 5.
6
The comparison of pleural fluid TNF-alpha and IL-10 levels with ADA in tuberculous pleural effusion.胸腔积液 TNF-α和 IL-10 水平与 ADA 在结核性胸腔积液中的比较。
Curr Med Chem. 2010;17(19):2096-100. doi: 10.2174/092986710791233652.
7
A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion.结核分枝杆菌伽马干扰素释放试验联合腺苷脱氨酶检测对结核性胸腔积液的诊断价值。
Emerg Microbes Infect. 2016 Aug 3;5(8):e83. doi: 10.1038/emi.2016.80.
8
Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值对结核性胸腔积液诊断的临床意义。
BMC Pulm Med. 2024 May 15;24(1):241. doi: 10.1186/s12890-024-03055-0.
9
Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.白细胞介素21和癌胚抗原水平在恶性胸腔积液中的诊断价值
Asian Pac J Cancer Prev. 2012;13(7):3495-9. doi: 10.7314/apjcp.2012.13.7.3495.
10
Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.触珠蛋白和可溶性CD163检测在结核性与恶性胸腔积液鉴别诊断中的临床价值
Medicine (Baltimore). 2019 Oct;98(42):e17416. doi: 10.1097/MD.0000000000017416.

引用本文的文献

1
Diagnostic Efficacy of C-Reactive Protein in Differentiating Various Causes of Exudative Pleural Effusion: Disease Research Should Not Be Exclusive to the Wealthy.C反应蛋白在鉴别渗出性胸腔积液各种病因中的诊断效能:疾病研究不应只为富人服务。
Adv Respir Med. 2025 Aug 5;93(4):29. doi: 10.3390/arm93040029.
2
Correlation Between Serum Inflammatory Factor Level Changes and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease Complicated by Tuberculosis.慢性阻塞性肺疾病合并肺结核患者血清炎症因子水平变化与疾病严重程度的相关性
Int J Gen Med. 2025 Jun 28;18:3547-3556. doi: 10.2147/IJGM.S522251. eCollection 2025.
3
The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model.
使用肿瘤标志物组合诊断恶性胸腔积液:基于堆叠模型的成本效益分析
Diagnostics (Basel). 2023 Oct 5;13(19):3136. doi: 10.3390/diagnostics13193136.
4
Analysis of CD4, CD8, CD19, CD56-16, CD64, QuantiFERON biomarkers in exudative lymphocyte-dominant pleural effusion.渗出性淋巴细胞为主型胸腔积液中CD4、CD8、CD19、CD56 - 16、CD64、QuantiFERON生物标志物的分析
J Family Med Prim Care. 2022 Nov;11(11):6843-6847. doi: 10.4103/jfmpc.jfmpc_2296_21. Epub 2022 Dec 16.
5
A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion.一项区分结核性和恶性胸腔积液的 Th1 和 Th2 细胞因子特征的荟萃分析。
Sci Rep. 2022 Feb 17;12(1):2743. doi: 10.1038/s41598-022-06685-8.
6
Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.胸腔积液干扰素-γ和腺苷脱氨酶检测对胸腔结核的诊断准确性比较:系统评价和荟萃分析。
PLoS One. 2021 Jun 24;16(6):e0253525. doi: 10.1371/journal.pone.0253525. eCollection 2021.
7
Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.癌症比率及其他新参数在恶性胸腔积液鉴别诊断中的作用
Clinics (Sao Paulo). 2021 Apr 26;76:e2515. doi: 10.6061/clinics/2021/e2515. eCollection 2021.
8
The Role of gp130 Cytokines in Tuberculosis.gp130 细胞因子在结核病中的作用。
Cells. 2020 Dec 15;9(12):2695. doi: 10.3390/cells9122695.